Yet SARS-CoV-2 infection of ACE2-expressing ECs remains to be demonstrated in COVID-19 patients and is at odds with current findings and additional studies indicating that ECs lack ACE2 (12, –, 14, 23). This evidence concerns the gene ACE2 and COVID-19.